New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Viking Therapeutics, Inc.
VKTX
Shape
US Flag

NASDAQ

Unprofitable

Unprofitable

9B

Biotechnology

78.03USD
Shape4.81 ( 6.57%)
favorite-chart

Relative Strenght

97
favorite-chart

Volume Buzz

175%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

22%

Quote Panel

Shape
Updated October 27, 2024
1W 21.28 % 1M 23.25 % 3M 27.40 % 1Y 714.51 %

Key Metrics

Shape
  • Market Cap

    8.65B


  • Shares Outstanding

    111.44M


  • Share in Float

    104.26M


  • Dividende

    0


  • Earning Date

    No Data


  • Price Target

    78.03


  • Average Volume

    3.31M


  • Beta

    0.998


  • Range

    9.15-99.41


  • Industry

    Biotechnology


  • Website

    https://www.vikingtherapeutics.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

19828.93x

P/S Ratio

9.50x

P/B Ratio

0.0

Debt/Equity

-22741.1%

Net Margin

$-0.9

EPS

How VKTX compares to sector?

P/E Ratio

Relative Strength

Shape

VKTX

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$3M

ShapeNaN%

2025-Revenue

$1.51

Shape-586%

2025-EPS

0

Analyst rating

No Data Available

Last analyst upgrade/downgrade

Morgan Stanley

initialise

Previous: Not converted

2024-06-27

Now: Overweight

Raymond James

upgrade

Previous: Not converted

2024-05-16

Now: Strong Buy

Earnings GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

N/A

-0.26
vs -0.16

Q1.23

arrow
arrow

N/A

-0.25
vs -0.21

Q2.23

arrow
arrow

N/A

-0.19
vs -0.23

Q3.23

arrow
arrow

N/A

-0.23
vs -0.21

Q4.23

arrow
arrow

N/A

-0.25
vs -0.26

Q1.24

arrow
arrow

N/A

-0.26
vs -0.25

Q2.24

arrow
arrow

N/A

-0.20
vs -0.19

Q3.24

arrow
arrow

N/A

-0.22
vs -0.23

Q4.24

arrow
arrow

N/A

-0.28
vs -0.25

Q1.25

arrow
arrow

N/A

-0.31
vs -0.26

Sales GrowthShape

status-upYoY

Current

Estimates

Q2.22

arrow
arrow

NA

NA  vs NA

Q3.22

arrow
arrow

NA

NA  vs NA

Q4.22

arrow
arrow

NA

NA  vs NA

Q1.23

arrow
arrow

NA

NA  vs NA

Q2.23

arrow
arrow

NA

NA  vs NA

Q3.23

arrow
arrow

NA

NA  vs NA

Q4.23

arrow
arrow

NA

436K  vs NA

Q1.24

arrow
arrow

NA

NA  vs NA

Q2.24

arrow
arrow

NA

NA  vs NA

Q3.24

arrow
arrow

NA

NA  vs NA

Return on EquityShape

status-upQoQ

Q4.22

arrow
arrow

-13%

-0.13
vs -0.10

Q1.23

arrow
arrow

-14%

-0.14
vs -0.13

Q2.23

arrow
arrow

-5%

-0.05
vs -0.14

Q3.23

arrow
arrow

-6%

-0.06
vs -0.05

Q4.23

arrow
arrow

-7%

-0.07
vs -0.06

Q1.24

arrow
arrow

-3%

-0.03
vs -0.07

Q2.24

arrow
arrow

-2%

-0.02
vs -0.03

Q3.24

arrow
arrow

-3%

-0.03
vs -0.02

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

109

109
vs 111

-2%

Q4.22

arrow
arrow

147

147
vs 109

35%

Q1.23

arrow
arrow

212

212
vs 147

44%

Q2.23

arrow
arrow

221

221
vs 212

4%

Q3.23

arrow
arrow

202

202
vs 221

-9%

Q4.23

arrow
arrow

220

220
vs 202

9%

Q1.24

arrow
arrow

425

425
vs 220

93%

Q2.24

arrow
arrow

428

428
vs 425

1%

Earnings Growth

Latest News

VKTX

schaeffersresearch.com

13 hours ago